EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Mesenchymal stem cell-based therapy for osteoarthritis: a systematic review and meta-analysis of clinical outcomes and functional recovery

Jincheng Wang, Hao Xue, Mingfei Shi, Renshou Chen

Frontiers in Cell and Developmental Biology · 06.01.2026 · 13

DOI: 10.3389/fcell.2025.1746471 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 06.01.2026. Verfasst von Jincheng Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Literature in Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Backgrounds This study aimed to evaluate the efficacy and safety of mesenchymal stem cell (MSC) therapy for osteoarthritis (OA) through a systematic review and meta-analysis of randomized controlled trials (RCTs), focusing on patient-reported pain and functional outcomes.

Methods

A comprehensive literature search was conducted across multiple databases including PubMed, Embase, Web of Science, and Cochrane Library from inception to 1st October 2025. RCTs comparing intra-articular MSC injections with control interventions (placebo, hyaluronic acid, or other active treatments) in adult OA patients were included. Primary outcomes were changes in pain intensity measured by Visual Analog Scale (VAS) and functional improvement assessed by International Knee Documentation Committee (IKDC) score. Secondary outcomes included Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Lequesne index, Lysholm score, and Tegner activity scale. Data were pooled using random-effects models and expressed as mean differences (MD) with 95% confidence intervals (CI).

Results

Eleven RCTs involving 811 patients were included. MSC therapy demonstrated significant reduction in VAS pain scores compared to controls (MD -4.08, 95% CI -5.56 to −2.61, p < 0.00001), with the most pronounced effects at 24-month follow-up (MD -3.31, 95% CI -5.18 to −1.44, p = 0.0005). Significant improvements were observed in IKDC scores (MD 2.88, 95% CI 0.28 to 5.47, p = 0.03), WOMAC index (MD -11.05, 95% CI -15.97 to −6.14, p < 0.0001), Lequesne index (MD -5.32, 95% CI -5.91 to −4.74, p < 0.00001), Lysholm score (MD 5.07, 95% CI 1.86 to 8.29, p = 0.002), and Tegner activity scale (MD 0.44, 95% CI 0.25 to 0.62, p < 0.00001). The therapeutic effects showed a time-dependent pattern, with maximal benefits observed at 24-month follow-up across all outcome measures.

Conclusion

Intra-articular MSC injection is an effective treatment for osteoarthritis, providing significant and durable improvements in pain relief, functional recovery, and activity levels up to 24 months post-treatment. The time-dependent nature of clinical benefits suggests a potential disease-modifying mechanism of action. MSC therapy represents a promising regenerative approach for OA management that warrants further investigation in large-scale trials.

Schlagwörter

Stichwörter der Autor:innen

cartilage repaircell therapyfunctional recoveryjoint preservationmesenchymal stem cellsmeta-analysisosteoarthritispain management

Autor:innen und Institutionen

  • Institute of Literature in Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
  • Jiangsu Provincial Research Institute of Chinese Medicine Schools, Nanjing, China.
  • School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.

Zitieren

APA

Wang, J., Xue, H., Shi, M., & Chen, R. (2026). Mesenchymal stem cell-based therapy for osteoarthritis: a systematic review and meta-analysis of clinical outcomes and functional recovery. Frontiers in Cell and Developmental Biology, 13. https://doi.org/10.3389/fcell.2025.1746471

Vancouver

Wang J, Xue H, Shi M, Chen R. Mesenchymal stem cell-based therapy for osteoarthritis: a systematic review and meta-analysis of clinical outcomes and functional recovery. Frontiers in Cell and Developmental Biology. 2026;13. doi:10.3389/fcell.2025.1746471

BibTeX
@article{Wang2026,
  author = {Wang, Jincheng and Xue, Hao and Shi, Mingfei and Chen, Renshou},
  title = {Mesenchymal stem cell-based therapy for osteoarthritis: a systematic review and meta-analysis of clinical outcomes and functional recovery},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcell.2025.1746471}
}
Kostenlos starten →